- The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib2011 | Third Faculty of Medicine
- Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment2021 | First Faculty of Medicine
- Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment2020 | Publication without faculty affiliation
- Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment2015 | Third Faculty of Medicine
- Inhalation of molecular hydrogen prevents ischemia-reperfusion liver damage during major liver resection2019 | Faculty of Pharmacy in Hradec Králové
- The pharmacokinetics of lamivudine in patients with impaired hepatic function1998 | Third Faculty of Medicine
- On the liver and atherosclerosis2019 | Second Faculty of Medicine
- The microbial flora in the digestive tract and diabetes2015 | First Faculty of Medicine
- Non-alcoholic steatosis and steatohepatitis2013 | First Faculty of Medicine
- Liver, kidneys and diabetes: three faces of HNF1B gene deficit2014 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- C-13-methacetin breath test in the evaluation of disease severity in patients with liver cirrhosis2013 | Third Faculty of Medicine
- Agomelatine - an antidepressant that restores circadian rhythms2012 | Publication without faculty affiliation
- Prevalence and clinical significance of liver function abnormalities in patients with acute heart failure2015 | First Faculty of Medicine, Third Faculty of Medicine
- Safety and effectiveness of aflibercept + fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) in current clinical practice: OZONE study2020 | Publication without faculty affiliation